Stage IIIA Mycosis Fungoides/Sezary Syndrome
specificStage IIIA includes: T4, N0-2, M0, B0. T4: Confluence of erythema covering 80% or more of body surface area. N0: No clinically abnormal peripheral lymph nodes; biopsy not required. N1: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 1 or NCI LN0-2. N2: Clinically abnormal peripheral lymph nodes; histopathology Dutch grade 2 or NCI LN3. M0: No visceral organ involvement. B0: Absence of significant blood involvement: 5% or less of peripheral blood lymphocytes are atypi
4
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IIIA Mycosis Fungoides/Sezary Syndrome(4)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 62.5 |
| 2 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 62.5 |
| 3 | Cleveland Clinic Cancer CenterCleveland, OH | 62.5 |
| 4 | University of Illinois Cancer CenterChicago, IL | 62.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →